
Sally Pipes: "CMS Undermining Next Generation of Medicines"
Treating distinct FDA-approved products as though they were the same drug doesn’t merely reinterpret the statute—it weakens the incentives that drive medical progress.
Benjamin Rush Institute seeks to educate medical students, residents, and students in affiliated fields of healthcare study about positive, proven healthcare policies that preserve and protect the doctor-patient relationship.
Subscribe:.rss.atom.json.md.m3u.pls
Live Last read · last published · next check
Saves to your Listen queue, to pick up on another day or another device.

Treating distinct FDA-approved products as though they were the same drug doesn’t merely reinterpret the statute—it weakens the incentives that drive medical progress.

Washington can mandate a lower price today. It cannot mandate robust competition tomorrow.

Drugmakers have already begun adjusting investment decisions in response to the Inflation Reduction Act and a new proposal to Medicare’s prescription drug price control scheme.

Some 8.43 million Britons have purchased private medical insurance to escape their National Health Service. Under leading Medicare for All proposals, Americans would not have that option.

California does not have a revenue problem. Objectively, it has a spending problem. A bad one, at that.

If more government is the solution, why have decades of expanding its regulatory powers only brought higher costs, fewer choices, and a dissolution of the doctor-patient relationship?

Cutting physician reimbursement may reduce spending on paper. But it also means fewer doctors, longer waits for appointments, and more care shifting into expensive hospital settings.

To function properly, markets require information. Patients and payers can’t reward lower-cost providers—and hospitals have little reason to compete—when prices are hidden.

Will the future of health care be decided by Congress, special interest groups, insurers, or conglomerates? Or will it instead be physicians who simply decide to practice differently?

For years, Medicare has paid for the complications of obesity while refusing to cover some of the most effective treatments for the disease itself. It's time to correct that contradiction.

If legislators make hiring a Medicaid recipient more expensive than hiring someone else, employers won't happily eat that cost. They will look for ways to avoid it.

Spending that buys longer, healthier lives is an investment. Spending driven by consolidation and distorted incentives is waste.

As hospitals have grown bigger and negotiated more restrictive contracts, prices for patients have only skyrocketed. Now, federal antitrust officials are beginning to take notice—and push back.

Fifteen years after ACA's passage, our healthcare system is less affordable, less competitive, and less fiscally sustainable. Yet many progressives argue for even greater government control.

Those who steal from programs intended to serve seniors, low-income families, and people with disabilities should expect to be caught. Taxpayers and patients deserve nothing less.

Medicaid grows larger, more expensive, and less focused every year. Work requirements will save taxpayers money, encourage upward mobility, and ensure Medicaid resources go to those who need it most.

In virtually every sector of the economy, consumers compare prices before making decisions. But in healthcare, prices are often hidden, allowing hospitals to engage in questionable pricing practices.

Hospitals are consolidating markets, exploiting federal programs and using their growing leverage to raise prices for patients and taxpayers alike. Why? Because federal policy incentivizes it.

If policymakers want more Americans to obtain coverage, they need to make insurance better and cheaper—not merely more heavily subsidized.

Are physicians in control of their own profession? Or are they effectively slaves to an uncaring bureaucracy?

Inflated enrollment totals by themselves are not signs of success. They are evidence of weak oversight, improper subsidy payments, and a system vulnerable to abuse.